Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.

La transmisión doméstica y la urbanización de la Leishmaniasis se han convertido en un fenómeno frecuente en Colombia y otros países de Latinoamérica. El desplazamiento de grupos humanos y la deforestación son factores que contribuyen. La adaptación de los vectores a hábitats alterados se evidencia...

Full description

Autores:
Rubiano, Luisa Consuelo
Tipo de recurso:
Investigation report
Fecha de publicación:
2010
Institución:
Ministerio de Ciencia, Tecnología e Innovación
Repositorio:
Repositorio Minciencias
Idioma:
spa
OAI Identifier:
oai:repositorio.minciencias.gov.co:20.500.14143/39571
Acceso en línea:
https://colciencias.metadirectorio.org/handle/11146/39571
http://colciencias.metabiblioteca.com.co
Palabra clave:
Leishmaniasis
Enfermedades transmisibles
Insectos vectores
Leishmaniasis mucocutánea
Cutaneous Leishmaniasis
Domestic Transmission
Human reservoir of infection
Microsatellite Genotyping
Parasite Burden
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
id RCENDOC_08b4bec63ec2fc03904a4d297177a286
oai_identifier_str oai:repositorio.minciencias.gov.co:20.500.14143/39571
network_acronym_str RCENDOC
network_name_str Repositorio Minciencias
repository_id_str
dc.title.spa.fl_str_mv Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
title Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
spellingShingle Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
Leishmaniasis
Enfermedades transmisibles
Insectos vectores
Leishmaniasis mucocutánea
Cutaneous Leishmaniasis
Domestic Transmission
Human reservoir of infection
Microsatellite Genotyping
Parasite Burden
title_short Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
title_full Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
title_fullStr Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
title_full_unstemmed Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
title_sort Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.
dc.creator.fl_str_mv Rubiano, Luisa Consuelo
dc.contributor.author.none.fl_str_mv Rubiano, Luisa Consuelo
dc.contributor.corporatename.spa.fl_str_mv Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) (Cali, Colombia)
dc.contributor.researchgroup.none.fl_str_mv COL0001413 - CIDEIM
dc.subject.armarc.none.fl_str_mv Leishmaniasis
Enfermedades transmisibles
Insectos vectores
Leishmaniasis mucocutánea
topic Leishmaniasis
Enfermedades transmisibles
Insectos vectores
Leishmaniasis mucocutánea
Cutaneous Leishmaniasis
Domestic Transmission
Human reservoir of infection
Microsatellite Genotyping
Parasite Burden
dc.subject.proposal.en.fl_str_mv Cutaneous Leishmaniasis
Domestic Transmission
Human reservoir of infection
Microsatellite Genotyping
Parasite Burden
description La transmisión doméstica y la urbanización de la Leishmaniasis se han convertido en un fenómeno frecuente en Colombia y otros países de Latinoamérica. El desplazamiento de grupos humanos y la deforestación son factores que contribuyen. La adaptación de los vectores a hábitats alterados se evidencia por la frecuencia y presencia diseminada geográficamente de Lutzomyia dentro de las viviendas. (Apartes del texto).
publishDate 2010
dc.date.issued.none.fl_str_mv 2010
dc.date.accessioned.none.fl_str_mv 2019-10-29T23:56:04Z
2020-12-18T00:35:58Z
dc.date.available.none.fl_str_mv 2019-10-29T23:56:04Z
2020-12-18T00:35:58Z
dc.type.spa.fl_str_mv Informe de investigación
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_93fc
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_18ws
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/report
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/PID
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/submittedVersion
http://purl.org/coar/version/c_71e4c1898caa6e32
info:eu-repo/semantics/submittedVersion
format http://purl.org/coar/resource_type/c_18ws
status_str submittedVersion
dc.identifier.uri.none.fl_str_mv https://colciencias.metadirectorio.org/handle/11146/39571
dc.identifier.instname.spa.fl_str_mv Colciencias
dc.identifier.reponame.spa.fl_str_mv Repositorio Colciencias
dc.identifier.repourl.spa.fl_str_mv http://colciencias.metabiblioteca.com.co
url https://colciencias.metadirectorio.org/handle/11146/39571
http://colciencias.metabiblioteca.com.co
identifier_str_mv Colciencias
Repositorio Colciencias
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.ispartofseries.none.fl_str_mv Informe;
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.format.extent.spa.fl_str_mv 45 páginas.
dc.coverage.spatial.none.fl_str_mv Colombia
institution Ministerio de Ciencia, Tecnología e Innovación
bitstream.url.fl_str_mv https://repositorio.minciencias.gov.co/bitstreams/38b8f756-d40f-4afc-9cd1-823d4a951d8f/download
https://repositorio.minciencias.gov.co/bitstreams/712fbe73-4b01-4050-be94-1941096802e2/download
https://repositorio.minciencias.gov.co/bitstreams/5ac29843-c356-4e90-a62f-ba2f220fe3c6/download
https://repositorio.minciencias.gov.co/bitstreams/499189be-58de-479d-a332-454592ec57e4/download
https://repositorio.minciencias.gov.co/bitstreams/1b8d5b9d-f088-4299-b107-0a3de7c78852/download
bitstream.checksum.fl_str_mv df57f40180745e04361c137b054ce1d0
88794144ff048353b359a3174871b0d5
d41d8cd98f00b204e9800998ecf8427e
f1a122fa4a70ca0c5cc80f76c2bdc217
66fde58c7aa521508773de211a65b867
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de Minciencias
repository.mail.fl_str_mv cendoc@minciencias.gov.co
_version_ 1811305876062994432
spelling Rubiano, Luisa Consuelo363c5e6a1e07e4c57853b093120537fa-1Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) (Cali, Colombia)COL0001413 - CIDEIMColombia2019-10-29T23:56:04Z2020-12-18T00:35:58Z2019-10-29T23:56:04Z2020-12-18T00:35:58Z2010https://colciencias.metadirectorio.org/handle/11146/39571ColcienciasRepositorio Colcienciashttp://colciencias.metabiblioteca.com.coLa transmisión doméstica y la urbanización de la Leishmaniasis se han convertido en un fenómeno frecuente en Colombia y otros países de Latinoamérica. El desplazamiento de grupos humanos y la deforestación son factores que contribuyen. La adaptación de los vectores a hábitats alterados se evidencia por la frecuencia y presencia diseminada geográficamente de Lutzomyia dentro de las viviendas. (Apartes del texto).45 páginas.spaInforme;Carga de infección humana en la transmisión doméstica y pérdida de susceptibilidad a medicamentos en la Leishmaniasis cutánea.Informe de investigaciónhttp://purl.org/coar/resource_type/c_18wshttp://purl.org/coar/resource_type/c_93fcTextinfo:eu-repo/semantics/reporthttps://purl.org/redcol/resource_type/PIDinfo:eu-repo/semantics/submittedVersionhttp://purl.org/coar/version/c_71e4c1898caa6e32info:eu-repo/semantics/submittedVersioninfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by/4.0/LeishmaniasisEnfermedades transmisiblesInsectos vectoresLeishmaniasis mucocutáneaCutaneous LeishmaniasisDomestic TransmissionHuman reservoir of infectionMicrosatellite GenotypingParasite BurdenEstudiantes, Profesores, Comunidad científica colombiana, etc.222951928948252-2010Departamento Administrativo de Ciencia, Tecnología e Innovación [CO] ColcienciasPrograma Nacional de CTeI en SaludProject Goal: To obtain the evidence base to prevent domestic transmission of dermal leishmaniasis and preserve the useful life of first line drugs by defining the burden of Leishmania infection (symptomatic and asymptomatic) in domestically exposed populations and the role of this reservoir of human infection in transmission, and the development and dissemination of drug resistance.Specific Aims : Aim 1. To determine the age-specific prevalence of parasites in blood, mucosa and dermal aspirates of the inhabitants of foci of domestic transmission of leishmaniasis. Research Questions ' What is the prevalence and relative burden of Leishmania in extralesional tissues of symptomatic and asymptomatic populations experiencing domestic transmission of dermal leishmaniasis? ' Is there an age, gender or clinical status bias in the prevalence and burden of parasites indicating that some individuals may be contributing more to transmission? Indicators ' Age specific prevalence of parasites in tissues of clinically apparent and subclinical infection established ' Individuals with high parasite burden identified Implementable outcomes 1. Magnitude of human reservoir of Leishmania infection in setting of domestic transmission estimated. 2. Quantitative reference point for assessment of subsequent interventions to reduce the burden of human infection determined. 3. Target populations for host directed interventions identified.Specific Aims : Aim 2. To discern the relationship between immunological evidence of infection (DTH response to intradermal application of Leishmania antigen-leishmanin) and the presence of parasites in host tissues (blood, mucosa and healthy skin). Research Questions ' Is skin test response correlated with the detectable presence of parasites in tissues? ' Can subclinical infection in the community be parasitologically established using molecular methods? Indicators ' Relationship between skin test response and persistence of parasites established. ' Capacity of molecular amplification of Leishmania DNA to parasitologically detect subclinical infection determined. Implementable outcome 1. A gene-based tool to parasitologically detect asymptomatic infection.Specific Aims : Aim 3. To determine the diversity and interrelationship of Leishmania populations circulating among the inhabitants of a focus of domestic transmission. Research Questions ' Are multiple populations of Leishmania distinguishable in domestic settings of transmission? ' Can the epidemiologic relationship of human infection with domestic transmission be discerned using phenotypic and genotypic markers? Indicators ' Diversity/similarity of Leishmania populations in representative settings of domestic transmission determined. ' Potential of phenotypic and genetic markers to discern epidemiologic relationships in the domestic setting defined. Implementable outcomes 1. Novel epidemiologic tools based on genotypic and functional markers 2. Genetic and phenotypic evidence of common or diverse sources of infection in the human population.Specific Aims : Aim 4. To define the drug susceptibility and persistence of parasites isolated from lesions and extralesional tissues before and after treatment. Research Questions ' Are parasites in blood, mucosa or healthy skin sites of treated patients less susceptible to the drug used to treat patients in the community? ' Is the parasite burden or drug susceptibility of recovered parasites correlated with the clinical response to treatment? Indicators ' In vitro drug susceptibility of parasites that disseminate to extralesional tissues and persist following treatment determined. ' Prevalence and relative burden of Leishmania in extralesional tissues following treatment established. Implementable outcomes 1. Recognition of treatment as a potential control measure for transmission 2. Evidence base to compel the use of combined therapies (co-adjuvant immunotherapy and/or antileishmanial drug combinations) to minimize burden of infection in human p.PublicationORIGINAL222951928948 20142430034272.pdf222951928948 20142430034272.pdfInforme Técnico Finalapplication/pdf11094401https://repositorio.minciencias.gov.co/bitstreams/38b8f756-d40f-4afc-9cd1-823d4a951d8f/downloaddf57f40180745e04361c137b054ce1d0MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-814798https://repositorio.minciencias.gov.co/bitstreams/712fbe73-4b01-4050-be94-1941096802e2/download88794144ff048353b359a3174871b0d5MD52license.txtlicense.txttext/plain; charset=utf-80https://repositorio.minciencias.gov.co/bitstreams/5ac29843-c356-4e90-a62f-ba2f220fe3c6/downloadd41d8cd98f00b204e9800998ecf8427eMD55TEXT222951928948 20142430034272.pdf.txt222951928948 20142430034272.pdf.txtExtracted texttext/plain45https://repositorio.minciencias.gov.co/bitstreams/499189be-58de-479d-a332-454592ec57e4/downloadf1a122fa4a70ca0c5cc80f76c2bdc217MD53THUMBNAIL222951928948 20142430034272.pdf.jpg222951928948 20142430034272.pdf.jpgGenerated Thumbnailimage/jpeg7169https://repositorio.minciencias.gov.co/bitstreams/1b8d5b9d-f088-4299-b107-0a3de7c78852/download66fde58c7aa521508773de211a65b867MD5420.500.14143/39571oai:repositorio.minciencias.gov.co:20.500.14143/395712023-11-29 17:33:07.454restrictedhttps://repositorio.minciencias.gov.coRepositorio Institucional de Mincienciascendoc@minciencias.gov.co